Lexington Realty Trust Announces Quarterly Common Share Dividend

NEW YORK, March 16, 2015 (GLOBE NEWSWIRE) -- Lexington Realty Trust (NYSE: LXP) ("Lexington") today announced that it declared a regular common share/unit dividend/distribution for the quarter ending March 31, 2015 of $0.17 per common share/unit payable on or about April 15, 2015 to common shareholders/unitholders of record as of March 31, 2015.

Lexington also announced that it declared a cash dividend of $0.8125 per share of Series C Cumulative Convertible Preferred Stock ("Series C Preferred Shares") for the quarter ending March 31, 2015. This Series C Preferred Share dividend is payable on or about May 15, 2015, to shareholders of record of Series C Preferred Shares as of April 30, 2015.

ABOUT LEXINGTON REALTY TRUST

Lexington Realty Trust is a real estate investment trust that owns a diversified portfolio of equity and debt interests in single-tenant commercial properties and land. Lexington seeks to expand its portfolio through acquisitions, sale-leaseback transactions, build-to-suit arrangements and other transactions. A majority of these properties and all land interests are subject to net or similar leases, where the tenant bears all or substantially all of the operating costs, including cost increases, for real estate taxes, utilities, insurance and ordinary repairs. Lexington also provides investment advisory and asset management services to investors in the single-tenant area. Lexington's common shares are traded on the New York Stock Exchange under the symbol "LXP". Additional information about Lexington is available on-line by contacting Lexington Realty Trust, Investor Relations, at www.lxp.com.

CONTACT: Investor Relations or
         Patrick Carroll, CFO
         212-692-7200
         [email protected]

You May Also Be Interested In

• Xsolla Announces Multi-Year Strategic Partnership With the Good Game Club Podcast to Amplify Positive Stories From the Global Games Industry
• Crypto News: Pepeto Exchange Security Upgrade While XRP Price Prediction Eyes $27 As Crypto Explodes
• Ingenia Therapeutics Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup